Inherited Retinal Dystrophy Due to RPE65 Mutations
2 clinical trials · Condition
◉ Watch Inherited Retinal Dystrophy Due to RPE65 Mutations
| Record | Firm | Date |
|---|---|---|
| Long-term Follow-up Study in Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2) (NCT03602820) | Genentech, Inc. | 2015-06-01 |
| Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis (NCT00999609) | Spark Therapeutics, Inc. | 2012-10-01 |
Track Inherited Retinal Dystrophy Due to RPE65 Mutations automatically
Every clearance here is in the API, with alerts when new ones post.